Interleukin-6 Overexpression Induces Pulmonary Hypertension
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Inflammatory cytokine interleukin (IL)-6 is elevated in the serum and lungs of patients with pulmonary artery hypertension (PAH). Several animal models of PAH cite the potential role of inflammatory mediators. We investigated role of IL-6 in the pathogenesis of pulmonary vascular disease. Indices of pulmonary vascular remodeling were measured in lung-specific IL-6–overexpressing transgenic mice (Tg + ) and compared to wild-type (Tg − ) controls in both normoxic and chronic hypoxic conditions. The Tg + mice exhibited elevated right ventricular systolic pressures and right ventricular hypertrophy with corresponding pulmonary vasculopathic changes, all of which were exacerbated by chronic hypoxia. IL-6 overexpression increased muscularization of the proximal arterial tree, and hypoxia enhanced this effect. It also reproduced the muscularization and proliferative arteriopathy seen in the distal arteriolar vessels of PAH patients. The latter was characterized by the formation of occlusive neointimal angioproliferative lesions that worsened with hypoxia and were composed of endothelial cells and T-lymphocytes. IL-6–induced arteriopathic changes were accompanied by activation of proangiogenic factor, vascular endothelial growth factor, the proproliferative kinase extracellular signal-regulated kinase, proproliferative transcription factors c-MYC and MAX, and the antiapoptotic proteins survivin and Bcl-2 and downregulation of the growth inhibitor transforming growth factor-β and proapoptotic kinases JNK and p38. These findings suggest that IL-6 promotes the development and progression of pulmonary vascular remodeling and PAH through proproliferative antiapoptotic mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Cellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Tuder, R. M., Groves, B. Μ., Badesch, D. B., & Voelkel, N. F. (1994) · PubMed · Cited by 891
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1355 · Cited by 885
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Pathologic assessment of vasculopathies in pulmonary hypertension
Pietra, G. G., Capron, F., Stewart, S., Leone, O., Humbert, M., Robbins, I. M., Reid, L. M., & Tuder, R. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.033 · Cited by 709
WAGENVOORT, C. A., & WAGENVOORT, N. (1970) · Circulation · doi:10.1161/01.cir.42.6.1163 · Cited by 562
Cited by
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Soon, E., Holmes, A. M., Treacy, C. M., Doughty, N. J., Southgate, L., Machado, R. D., Trembath, R. C., Jennings, S., Barker, L., Nicklin, P., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933762 · Cited by 802
Mechanisms of disease: pulmonary arterial hypertension
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 800
Lee, C., Mitsialis, S. A., Aslam, M., Vitali, S. H., Vergadi, E., Konstantinou, G., Sdrimas, K., Fernandez-Gonzalez, A., & Kourembanas, S. (2012) · Circulation · doi:10.1161/circulationaha.112.114173 · Cited by 793
Stenmark, K. R., Meyrick, B., Galie, N., Mooi, W. J., & McMurtry, I. F. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2009 · Cited by 774
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Autophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
“This pro-inflammatory state is correlated with poorer outcomes, a concept that is mimicked in in vivo studies.(84,85) Further investigations revealed a potential pathogenic role for inflammasome activation in the development of PH when mice lacking the inflammasome adaptor protein PYCARD/ASC (PYD and CARD domain conta…”
BackgroundRole for miR-204 in human pulmonary arterial hypertension
Courboulin, A., Paulin, R., Giguère, N. J., Saksouk, N., Perreault, T., Meloche, J., Paquet, E. R., Biardel, S., Provencher, S., Côté, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101812 · Cited by 523
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
Pathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Inflammation in Pulmonary Arterial Hypertension
Price, L. C., Wort, S. J., Perros, F., Dorfmüller, P., Huertas, A., Montani, D., Cohen-Kaminsky, S., & Humbert, M. (2012) · Chest · doi:10.1378/chest.11-0793 · Cited by 403
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Pacurari, M., Kafoury, R., Tchounwou, P. B., & Ndebele, K. (2014) · International Journal of Inflammation · doi:10.1155/2014/689360 · Cited by 374
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
Savale, L., Tu, L., Rideau, D., Izziki, M., Maitre, B., Adnot, S., & Eddahibi, S. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-6 · Cited by 313
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension
Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y. K., Gera, L., Patterson, A. J., Agrawal, R., Rabinovitch, M., Ambler, K., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.236927 · Cited by 306
Pathobiology of pulmonary arterial hypertension and right ventricular failure
Voelkel, N. F., Gomez-Arroyo, J., Abbate, A., Bogaard, H. J., & Nicolls, M. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00046612 · Cited by 274
Vergadi, E., Chang, M. S., Lee, C., Liang, O. D., Liu, X., Fernandez-Gonzalez, A., Mitsialis, S. A., & Kourembanas, S. (2011) · Circulation · doi:10.1161/circulationaha.110.978627 · Cited by 267
Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y.-Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060269 · Cited by 265
Self-citationHashimoto-Kataoka, T., Hosen, N., Sonobe, T., Arita, Y., Yasui, T., Masaki, T., Minami, M., Inagaki, T., Miyagawa, S., Sawa, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424774112 · Cited by 260
El Kasmi, K. C., Pugliese, S. C., Riddle, S. R., Poth, J. M., Anderson, A. L., Frid, M. G., Li, M., Pullamsetti, S. S., Savai, R., Nagel, M. A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303048 · Cited by 245
“remodeling/fibrosis, including models in which mice overexpressing IL-6 display severe hypoxia-induced PH accompanied by inflammatory vascular remodeling, whereas mice genetically deficient in IL-6 are protected from PH (30, 32).”
BackgroundLi, M., Riddle, S. R., Frid, M. G., El Kasmi, K. C., McKinsey, T. A., Sokol, R. J., Strassheim, D., Meyrick, B., Yeager, M. E., Flockton, A. R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100479 · Cited by 239
Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension.
Lee, S.-J., Smith, A., Guo, L., Alastalo, T.-P., Li, M., Sawada, H., Liu, X., Chen, Z.-H., Ifedigbo, E., Jin, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0746oc · Cited by 217
“In two independent mouse models that develop spontaneous PH, including transgenic mice overexpressing IL-6 Tg (36) and mice genetically deleted for vasoactive intestinal peptide (37) (Lee, Smith, and Choi, unpublished data), we also have observed elevated activation of LC3B in the lungs of mice from both of these mode…”
BackgroundRicard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007469 · Cited by 208
Murine Models of Heart Failure With Preserved Ejection Fraction
Valero-Muñoz, M., Backman, W., & Sam, F. (2017) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.07.013 · Cited by 206
The cancer theory of pulmonary arterial hypertension
Boucherat, O., Vitry, G., Trinh, I., Paulin, R., Provencher, S., & Bonnet, S. (2017) · Pulmonary Circulation · doi:10.1177/2045893217701438 · Cited by 202
“Reprints and permissions: sagepub.co.uk/journalsPermissions.nav journals.sagepub.com/home/pul Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commer…”
BackgroundInfluentialInflammatory cytokines in pulmonary hypertension
Groth, A., Vrugt, B., Brock, M., Speich, R., Ulrich, S., & Huber, L. C. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-47 · Cited by 197
“When these rats were treated with immunosuppressive steroids decreased levels of IL-6 and reduced pulmonary pressures and RVH were measured [37].”
BackgroundInfluentialHuertas, A., Perros, F., Tu, L., Cohen-Kaminsky, S., Montani, D., Dorfmüller, P., Guignabert, C., & Humbert, M. (2014) · Circulation · doi:10.1161/circulationaha.113.004555 · Cited by 194
“2,60 We recently showed that platelet-derived growth factor, fibroblast growth factor-2, and platelet-derived growth factor signaling pathways converge to p130Cas, an adaptor protein modulating several signaling pathways that controls cell migration and proliferation and acts as an amplifier of downstream signals.61 W…”
BackgroundBromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension
Meloche, J., Potus, F., Vaillancourt, M., Bourgeois, A., Johnson, I., Deschamps, L., Chabot, S., Ruffenach, G., Henry, S., Breuils-Bonnet, S., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.307004 · Cited by 183
Role for Interleukin-6 in COPD-Related Pulmonary Hypertension
Chaouat, A., Savale, L., Chouaid, C., Tu, L., Sztrymf, B., Canuet, M., Maitre, B., Housset, B., Brandt, C., Le Corvoisier, P., et al. (2009) · Chest · doi:10.1378/chest.08-2420 · Cited by 180
“Social Life” of Senescent Cells: What Is SASP and Why Study It?
Borodkina, A. V., Deryabin, P. I., Giukova, А. А., & Nikolsky, N. N. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-4-14 · Cited by 170
Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies
Kayser, B., & Verges, S. (2013) · Obesity Reviews · doi:10.1111/obr.12034 · Cited by 164
“(84) used a mouse model overexpressing IL-6 and found vasculopathy typical of pulmonary arterial hypertension patients, increased pulmonary artery pressure and right heart loading, all of which were exacerbated by hypoxia.”
MethodPathophysiology of pulmonary hypertension in acute lung injury
Price, L. C., McAuley, D. F., Marino, P. S., Finney, S. J., Griffiths, M. J., & Wort, S. J. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2011 · Cited by 161
Role of Interleukin-6 in Vascular Health and Disease
Villar-Fincheira, P., Sanhueza-Olivares, F., Norambuena-Soto, I., Cancino-Arenas, N., Hernandez-Vargas, F., Troncoso, R., Gabrielli, L., & Chiong, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.641734 · Cited by 154
The Fountain of Youth by Targeting Senescent Cells?
de Keizer, P. L. J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.006 · Cited by 127
Kelley, E. E., Baust, J., Bonacci, G., Golin-Bisello, F., Devlin, J. E., St. Croix, C. M., Watkins, S. C., Gor, S., Cantu-Medellin, N., Weidert, E. R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt341 · Cited by 95
Metadata
- Authors
- Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., & Waxman, A. B.
- Venue
- Circulation Research
- Published
- 2009-01-30
- Volume
- 104
- Issue
- 2
- Pages
- 236-244
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2145237733
- Cited by
- 655
- References
- 50
- FWCI
- 23.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.